CytRx News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

18.04.18	Hero Wipes® to Unveil New Bloodborne Pathogen Antiseptic Wipes for EMS Providers at FDIC 2018 (PR Newswire)
12.12.17	Epson Expands its WorkForce Wide-Format Printer Series, Powered by PrecisionCore (PR Newswire)
08.11.17	CytRx Reports Third Quarter 2017 Financial Results (PR Newswire)
02.11.17	CytRx Corporation Highlights Recent Progress at Freiburg, Germany, Laboratory and Provides Update for Oncology Pipeline (PR Newswire)
01.11.17	AZN Gets Speedy Nod, RBP-6000 Just One Step Away From Approval, STML Soars (RTTNews)
31.10.17	CytRx Corporation Announces Reverse Stock Split (PR Newswire)
27.10.17	CytRx Corporation Announces Results from Special Meeting of Stockholders (PR Newswire)
24.10.17	Lifshitz & Miller LLP Announces Investigation of Antares Pharma, Inc., CenturyLink, Inc., CytRx Corporation, Dentsply Sirona, Inc., Dr. Reddy's Laboratories Limited, J.Jill, Inc., and Navient... (PR Newswire)
17.10.17	CytRx Corporation Announces Outcome of Nasdaq Hearing (PR Newswire)
12.10.17	CytRx Corporation Highlights Inclusion of Aldoxorubicin in Pending Upcoming Clinical Trial Submissions Planned By Licensee NantCell, Inc. (PR Newswire)
04.10.17	Johnson Fistel, Announces Investigations of NantKwest, Inc., K12 Inc., and CytRx Corporation; Long-Term Investors Encouraged to Contact Firm (PR Newswire)
04.10.17	Institutional Shareholder Services, Inc., Recommends CytRx Corporation Stockholders Vote "FOR" the Proposed Reverse Stock Split (PR Newswire)
02.10.17	CytRx Corporation Provides Business Update and Highlights Future Plans (PR Newswire)
21.09.17	Leading Independent Proxy Advisory Firm Glass Lewis & Co. Recommends CytRx Corp. Stockholders Vote "FOR" the Proposed Reverse Stock Split (PR Newswire)
13.09.17	CytRx Corporation Announces Amendment to Definitive Proxy Statement for Upcoming Special Meeting (PR Newswire)
05.09.17	Recent Developments in the Pharmaceutical Industry (PR Newswire)
30.08.17	CytRx Corporation Files Definitive Proxy Statement for Upcoming Special Meeting (PR Newswire)
25.08.17	ADMS Soars On FDA Nod, EARS Gets An Earful, Thumbs Up For BIIB's Humira Biosim (RTTNews)
24.08.17	CytRx Corporation Announces Receipt of NASDAQ Listing Determination (PR Newswire)
08.08.17	Breakfast Technical Briefing on Biotech Stocks -- CytRx, Aeterna Zentaris, Capricor Therapeutics, and Cymabay Therapeutics (PR Newswire)
07.08.17	Actor Joseph Gordon-Levitt to be Closing Keynote Speaker at Content Marketing World 2017 (PR Newswire)
03.08.17	CytRx Reports Second Quarter 2017 Financial Results (PR Newswire)
31.07.17	DVAX Surges On FDA Panel Vote, CYTR On Watch, EU Approves New HCV Drugs (RTTNews)
28.07.17	CytRx Corporation Announces Global Strategic License With NantCell Inc. For Aldoxorubicin, An Albumin Mediated Chemotherapeutic (PR Newswire)
22.06.17	Breakfast Technical Briefing on Biotech Stocks -- CytRx, Keryx Biopharma, TG Therapeutics, and ZIOPHARM Oncology (PR Newswire)
13.06.17	CytRx Announces Reshaping of Clinical and Regulatory Executive Team (PR Newswire)
08.06.17	CytRx Announces Update on the Regulatory Pathway for Aldoxorubicin in Soft Tissue Sarcomas (PR Newswire)
17.05.17	CytRx to Present Global Phase 3 Aldoxorubicin Clinical Data in Patients with Soft Tissue Sarcomas at the 2017 American Society of Clinical Oncology Annual Meeting (PR Newswire)
10.05.17	CytRx Reports First Quarter 2017 Financial Results (PR Newswire)
28.04.17	CytRx Corporation Announces Pricing of $15 Million Public Offering of Common Stock (PR Newswire)
27.04.17	CytRx Corporation Announces Proposed Public Offering of Common Stock (PR Newswire)
21.04.17	CytRx to Present Aldoxorubicin Clinical Trial Data in Patients with Soft Tissue Sarcomas at the 2017 American Society of Clinical Oncology Annual Meeting (ASCO) (PR Newswire)
19.04.17	CytRx Announces FDA Agreement on Regulatory Pathway to Approval for Aldoxorubicin in Soft Tissue Sarcomas (PR Newswire)
18.04.17	Technical Reports on Biotech Stocks -- CytRx, Achaogen, Jaguar Animal, and Illumina (PR Newswire)
15.03.17	CytRx Reports 2016 Financial Results (PR Newswire)
07.03.17	CytRx to Present at the 29th Annual ROTH Conference (PR Newswire)
02.03.17	Technical Reports on Biotech Stocks -- Halozyme Therapeutics, CytRx, Cara Therapeutics, and Keryx Biopharma (PR Newswire)
06.02.17	CytRx to Present at the 19th Annual BIO CEO & Investor Conference (PR Newswire)
04.01.17	CytRx Granted Type B Pre-NDA Meeting with U.S. FDA for Registration Pathway with Aldoxorubicin as a Treatment for Patients with Relapsed Soft Tissue Sarcomas (PR Newswire)
28.12.16	Biotech Stocks on Investors' Radar -- Eleven Biotherapeutics, Illumina, Sangamo Biosciences, and CytRx (PR Newswire)
19.12.16	CytRx Appoints Chief Medical Officer Dr. Daniel Levitt as Chief Operating Officer (PR Newswire)
29.11.16	CytRx Reports Statistically Significant Updated Results from Pivotal Phase 3 Trial of Aldoxorubicin in Patients with Second-Line Soft Tissue Sarcomas (PR Newswire)
22.05.15	OTIC Data No Music To Ears, KMPH's Filing On Track, BIOD For The Long Haul (RTTNews)
04.05.15	Busy Period Ahead For CYTR, NBY Put On Notice, SRNE Surges On Cynviloq Deal (RTTNews)
09.01.15	FOLD Unfolds, No Pain, All Gain For NBIX, VSAR Picks Up Velocity, RVNC On Watch (RTTNews)
07.01.15	ALKS Moves Forward, KBIO Craters, GILD Opens Wallet, TRVN For The Long Haul (RTTNews)
06.01.15	MÄRKTE USA/Wall Street erneut von Ölpreisverfall belastet (Dow Jones)
19.11.14	AGIO's Stellar Run, ONVO's Much Awaited Day, CYTR Slides For A Reason (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu CytRx Corp

Aktien Top/Flop

Meistgelesene Nachrichten